Ask AI
ProCE Banner Activity

Tuning In to TYK2: Innovation in Oral Psoriasis Treatment for NPs and PAs

Slideset

Expert-curated slides on the pathophysiology of psoriasis, TYK2 inhibitor selectivity, and how oral, small molecule therapies are transforming the treatment landscape for patients with moderate to severe disease. 

Released: October 16, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners)

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb